News Home

Should You Buy TherapeuticsMD Inc (TXMD) Stock Monday?

Monday, February 08, 2021 08:04 AM | InvestorsObserver Analysts
Should You Buy TherapeuticsMD Inc (TXMD) Stock Monday?

TherapeuticsMD Inc (TherapeuticsMD Inc (TXMD)) is higher by Monday morning, with the stock climbing 30.53% in pre-market trading to 2.48.

TXMD's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 103 out of 146 industries, the stock ranks higher than 21% of stocks.

TherapeuticsMD Inc has risen 42.86% over the past month, closing at $1.42 on January 11. During this period of time, the stock fell as low as $1.37 and as high as $1.98. TXMD has an average analyst recommendation of Strong Buy. The company has an average price target of $7.40.

Overall Score - 39
TXMD has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on TXMD!

TherapeuticsMD Inc has a Long-Term Technical rank of 13. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 87% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 36 by this metric, TXMD ranks better than 15% of stocks.

Important Dates for Investors in TXMD:

-TherapeuticsMD Inc is set to release earnings on 2/18/2021. During their last earnings release the company posted EPS of $-0.71. -We do not have a set dividend date for TherapeuticsMD Inc at this time. Click Here to get the full Stock Score Report on TherapeuticsMD Inc (TXMD) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App